Amneal Pharma and mAbxience Secure USFDA Approval for Denosumab Biosimilars Boncresa and Oziltus
Amneal Pharmaceuticals and mAbxience, a majority-owned subsidiary of Fresenius Kabi with partial ownership from Insud Pharma, have received U.S. Food […]
